TriGenex

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

Bifidobacterium infantis, Quantity: 3.2 billion CFU; Bifidobacterium longum, Quantity: 4.1 billion CFU; Bifidobacterium breve, Quantity: 4 billion CFU

MAH:

Biomedica Nutraceuticals Pty Ltd

INN:

Bifidobacterium breve,Bifidobacterium infantis,Bifidobacterium longum

pharmaceutical_form:

Capsule, hard

composition:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; tricalcium phosphate; tapioca starch; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum

administration_route:

Oral

therapeutic_indication:

Maintain/support general health and wellbeing ; Maintain/support healthy digestive system function ; Maintain/support healthy digestion ; Maintain/support digestive system health ; Maintain/support intestinal good/beneficial/friendly flora ; Helps restore good/beneficial/friendly intestinal/gut/bowel flora ; Maintain/support immune system health ; Maintain/support healthy immune system function

leaflet_short:

Visual Identification: ;

authorization_status:

Licence status A

authorization_date:

2017-06-30